Skip to content

To compare the combined efficacy of internal administration of Jeevantyadi ghrita and Mahatriphaladya ghrita tarpana with Mahatriphaladya Ghrita Tarpana alone in Simple myopia

A Randomized Control Trial of Jeevantyadi Ghritapana and Mahatriphaladya Ghrita Tarpana in Timira with special reference to Simple Myopia

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/02/040241
Enrollment
60
Registered
2022-02-11
Start date
Unknown
Completion date
Unknown
Last updated
2022-02-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H521- Myopia

Interventions

None listed

Sponsors

Athira K Prasad
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients attending the OPD of our research institute in age group between 15 to 30 years having simple myopia will be randomly selected. 2. Patients having a vision of 6/9 or less ie.,6/12, 6/18, 6/24,6/36,6/60 3. Patients having refractive error -0.5D to -3.00D

Exclusion criteria

Exclusion criteria: 1. Patients having any known systemic disorders will be excluded from the study 2. Patients having any other known ocular pathology eg. Cataract, corneal opacity, H/o iridocyclitis, retinal pathologies. 3. Patients suffering from eye disorders of systemic origin 4. Patients below the age of 15 years and above 30 years are excluded 5. Non Co - operative patients

Design outcomes

Primary

MeasureTime frame
To study the combined effect of Jeevantyadi ghritapana and Mahatriphaladya Ghrita tarpana in Timira with respect to simple myopiaTimepoint: 18 months

Secondary

MeasureTime frame
To assess the efficacy of shamana snehapana in simple myopia To assess the local effect of Tarpana in management of Timira with special reference to Simple MyopiaTimepoint: 18 months

Countries

India

Contacts

Public ContactR D Deshmukh

Government Ayurveda College and hospital Nagpur

rd.deshmukh14@gmail.com9423681483

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026